Qianhai Health : BUSINESS DEVELOPMENT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Qianhai Health Holdings Limited

前 海 健 康 控 股 有 限 公 司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 911)

BUSINESS DEVELOPMENT

This announcement is made by Qianhai Health Holdings Limited (the "Company", together with its subsidiaries, the "Group") on a voluntary basis to inform its shareholders and potential investors of the latest business development of the Group.

The board (the "Board") of directors (the "Directors") of the Company is pleased to

announced that on 1 April 2021, the Company entered into a strategic cooperation agreement (the "Cooperation Agreement") with 深圳市睦融健康管理有限公司 (Shenzhen Murong Health Management Limited*) ("Murong").

The Group is principally engaged in sale of healthcare products and electronic component products. Murong is mainly engaged in providing healthcare related services. According to the Cooperation Agreement, the Company and Murong shall launch a strategic cooperation to carry out business in healthcare industries and related fields, and jointly build an industry benchmark brand for healthcare products.

To the Directors' knowledge, information and belief, and having made all reasonable enquiries, Murong and its ultimate beneficial owners are independent third parties and not connected with the Company or any of its connected persons.

1

By virtue of entering into the Cooperation Agreement, the Group can integrate its sales network of healthcare products into distribution channels and other platforms in order to expand its business of healthcare products in China. Accordingly, the Board considers that the entering into of the Cooperation Agreement is in the interests of the Company and its shareholders as a whole.

The Group may or may not enter into further legally binding agreements in respect of the formal cooperation which may or may not materialise. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the shares of the Company.

By order of the Board

Qianhai Health Holdings Limited

Huang Guanchao

Chairman

Hong Kong, 1 April 2021

As at the date of this announcement, the non-executive Directors are Mr. Huang Guanchao and Mr. Lim Tzea; the executive Directors are Mr. Xu Keli and Mr. Lam Hin Chi and the independent non-executive Directors are Mr. Li Wei, Mr. Wu Wai Leung Danny and Mr. Yuen Chee Lap Carl.

• For identification purpose only

2